Journey Medical (DERM) Total Liabilities (2020 - 2026)
Journey Medical's (DERM) quarterly Total Liabilities came in at $60.7 million in Q1 2026, down 4.29% YoY from $63.4 million in Q1 2025, and down 3.24% on a QoQ basis from $62.7 million in Q4 2025.
Journey Medical (DERM) Total Liabilities (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Total Liabilities data on file, last reported at $60.7 million in Q1 2026.
- Quarterly Total Liabilities fell 4.29% year-over-year to $60.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.7 million (down 4.29% YoY) and the FY2025 annual result came in at $62.7 million, up 4.26% from the prior year.
- Total Liabilities declined to $60.7 million in Q1 2026, from $62.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $88.4 million in Q1 2023 to a low of $48.5 million in Q3 2023.
- A 5-year average of $65.9 million and a median of $61.9 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 59.62% — and 2023, when it tumbled 40.77%.
- Tracing DERM's Total Liabilities over 5 years: stood at $88.2 million in 2022, then sank by 35.93% to $56.5 million in 2023, then rose by 6.5% to $60.2 million in 2024, then rose by 4.26% to $62.7 million in 2025, then declined by 3.24% to $60.7 million in 2026.
- The last three Total Liabilities figures came in at $60.7 million (Q1 2026), $62.7 million (Q4 2025), and $59.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Journey Medical | 207.85 Mn | 182.21 Mn | 12.37 Mn | 66.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.24 Mn |
| Mar 31, 2026 | 60.70 Mn |
| Dec 31, 2025 | 62.74 Mn |
| Sep 30, 2025 | 59.29 Mn |
| Jun 30, 2025 | 61.91 Mn |
| Mar 31, 2025 | 63.42 Mn |
| Dec 31, 2024 | 60.17 Mn |
| Sep 30, 2024 | 53.12 Mn |
| Jun 30, 2024 | 53.89 Mn |
| Mar 31, 2024 | 53.62 Mn |
| Dec 31, 2023 | 56.50 Mn |
| Sep 30, 2023 | 48.54 Mn |
| Jun 30, 2023 | 69.74 Mn |
| Mar 31, 2023 | 88.36 Mn |
| Dec 31, 2022 | 88.18 Mn |
| Sep 30, 2022 | 81.96 Mn |
| Jun 30, 2022 | 78.70 Mn |
| Mar 31, 2022 | 79.46 Mn |
| Dec 31, 2021 | 55.24 Mn |
| Sep 30, 2021 | 100.77 Mn |